FAMILIAL THALASSEMIA AND ERYTHREMIC MYELOSIS
1 Department of Pediatrics, and the Hematology Service of the Department of Laboratories, The Long Island Jewish Hospital
A patient with familial thalassemia who developed a myeloproliferative disorder with bidirectional involvement has been studied. It is suggested that because of the inherited red cell defect predominant expression was in the erythroid system.
Some of the hazards attendant upon prolonged adrenal-steroid and antibiotic therapy and splenectomy are discussed.
Submitted on January 3, 1958Accepted on February 7, 1958




